You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Moodys
Express Scripts
McKinsey

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

Betamethasone benzoate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for betamethasone benzoate and what is the scope of freedom to operate?

Betamethasone benzoate is the generic ingredient in one branded drug marketed by Parke Davis and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone benzoate.

Summary for betamethasone benzoate
US Patents:0
Tradenames:1
Applicants:1
NDAs:4
Drug Master File Entries: 66
Bulk Api Vendors: 15
Patent Applications: 1,378
DailyMed Link:betamethasone benzoate at DailyMed
Synonyms for betamethasone benzoate
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione17-benzoate
(11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl benzoate
22298-29-9
877K0XW47A
9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl benzoate, (11.beta.,16.beta.)-#
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-benzoate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-benzoate
Beben
Benisone
Betamethasone 17-benzoate
Betamethasone benzoate (USP)
Betamethasone benzoate [USAN:USP]
betamethasone-17-benzoate
Bethamethasone 17-benzoate
CHEBI:135798
CHEMBL1200376
CS-7216
D02286
DTXSID2022670
EINECS 244-897-9
Euvaderm
Flurobate
FT-0696623
HY-U00161
MS 1112
Parbetan
Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-, 17-benzoate
Q27269802
SCHEMBL49469
SOQJPQZCPBDOMF-YCUXZELOSA-N
UNII-877K0XW47A
Uticort
Uticort (TN)
W 5975
W-5975
ZINC4212134

US Patents and Regulatory Information for betamethasone benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis UTICORT betamethasone benzoate CREAM;TOPICAL 016998-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate OINTMENT;TOPICAL 018089-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate GEL;TOPICAL 017244-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate LOTION;TOPICAL 017528-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Moodys
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.